Loading...
menu
Search
AI Chat
AI Strategies
Products
Markets
News
Resources
Pricing
Home
ETF
CGON
CGON
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
CGON News
Oncolytics Biotech Advances Pelareorep for Anal Cancer with 29% Response Rate
Jan 12 2026
PRnewswire
Oncolytics Biotech Advances Pelareorep for Anal Cancer with 29% Response Rate
Jan 12 2026
Newsfilter
Rich Sparkle Holdings Signs $39 Million Share Offering Agreement
Jan 09 2026
Benzinga
CG Oncology Accelerates Phase 3 Data Readout to First Half of 2026
Jan 09 2026
Benzinga
CG Oncology Accelerates PIVOT-006 Data Timeline to 1H 2026
Jan 09 2026
Globenewswire
Inaugural Week of CGON Options Trading for February 2026
Dec 19 2025
NASDAQ.COM
CG Oncology Partners with SUO-CTC to Establish $50,000 NMIBC Research Fellowship
Dec 18 2025
Newsfilter
Three Stocks with Significant Growth Potential, According to Top Analysts – 11/27/2025
Nov 27 2025
TipRanks
CG Oncology Appoints Christina Rossi to Board of Directors Amid BLA Initiation
Nov 26 2025
Newsfilter
CG Oncology Appoints Christina Rossi to Board of Directors Amid BLA Initiation
Nov 26 2025
Globenewswire
CG Oncology Aims to Finalize BLA Submission for Cretostimogene in Bladder Cancer by 2026
Nov 17 2025
NASDAQ.COM
Implications of CG Oncology's FDA BLA Submission and Phase 3 Advancements for Investors
Nov 15 2025
Yahoo Finance
Significant Options Activity on Tuesday: CGON, DECK, ARQT
Oct 28 2025
NASDAQ.COM
Guggenheim Initiates Buy Rating for CG Oncology (CGON)
Oct 18 2025
Yahoo Finance
After-Hours Surge Boosts PALI, HCTI, NTRB, KPTI, EDIT, and CGON Amid Mixed News and Strategic Actions
Oct 10 2025
NASDAQ.COM
Reasons Behind Cg Oncology's 7% Surge in Stock Price Today
Oct 08 2025
NASDAQ.COM
Show More News
